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 Retinal dystrophies display a high degree of clinical and
genetic heterogeneity. Frequently, a single disease may be
caused by mutations in a multitude of different genes, and in
some cases, mutations in a single gene may lead to clinically
distinct diseases. One such gene is the retina specific ATP-
binding cassette transporter (ABCA4) gene. Mutations in the
ABCA4 gene have been shown to cause most cases of autoso-
mal recessive Stargardt disease (STGD1; OMIM number
248200), a significant fraction of cases of autosomal reces-
sive cone-rod dystrophy (arCRD; OMIM number 604116), and
in some cases mutations in ABCA4 were found in patients suf-
fering from autosomal recessive retinitis pigmentosa (arRP)
[1-16]. ABCA4 has also been suggested to be a susceptibility
factor for age-related macular degeneration (AMD) [17,18].
ABCA4 is a member of the ATP-binding cassette (ABC)
transporter gene superfamily and encodes the ABCR protein.
ABCR is located at the rim of the outer segment disks of rod
and cone photoreceptors [19,20] and is involved in the trans-
port of all-trans-retinaldehyde across photoreceptor disk mem-
branes from the lumen to the photoreceptor cytoplasm through
a flippase activity [21-23]. Mutations in ABCA4 lead to an
accumulation of all-trans-retinal inside the photoreceptor disk
lumen. This free all-trans-retinal is unfavorable and therefore
Schiff-bonded to phosphatidyl ethanolamine. This bondage
leads to toxic levels of N-retinylidene-N-retinylethanolamine
(A2E) in the retinal pigment epithelium (RPE), which results
in RPE cell apoptosis, followed by irreversible photoreceptor
cell death [23-25].
The variability of severity in the different diseases asso-
ciated with ABCA4 mutations has led to a genotype-pheno-
type model in which the residual activity of the mutated ABCR
protein is inversely correlated with the severity of the retinal
dystrophy [2,12]. This model predicts that two severe (null)
mutations may lead to arRP, a combination of a severe with a
moderately severe mutation may result in cone-rod dystrophy
(CRD), and two moderate or a severe and a mild mutation
may lead to STGD1 [4].
We present a pedigree displaying both arCRD and STGD1
in which some of the causative mutations in ABCA4 were iden-
tified with the Affymetrix Gene Chip® CustomSeq™
Resequencing Array (arRP-I) [26]. This technique allowed us
to identify two novel ABCA4 mutations. Further, we show the
ABCA4-associated CRD and STGD1 phenotypes and reveal a
new clinical feature, nystagmus.
METHODS
 This study was approved by the Institutional Review Board
of the Montreal Children’s Hospital in Montreal and the pro-
tocol adhered to the Declaration of Helsinki. The three arCRD
patients were patients in our clinic and were enrolled in this
study. We were able to collect blood samples from five addi-
tional individuals. In total we recruited five women (1 arCRD
and 1 STGD1 patient) and three men (2 arCRD patients). All
persons signed informed consent.
©2007 Molecular Vision
Molecular and phenotypic analysis of a family with autosomal
recessive cone-rod dystrophy and Stargardt disease
Suzanne Yzer,1,2, L. Ingeborgh van den Born,1 Marijke N. Zonneveld,2 Irma Lopez,3 Radha Ayyagari,4 Leonard
Teye-Botchway,5 Luisa Mota-Vieira,6,7 Frans P. M. Cremers,2,8 Robert K. Koenekoop3
1The Rotterdam Eye Hospital, Rotterdam; 2Department of Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen,
The Netherlands; 3McGill Ocular Genetics Laboratory, McGill University Health Center, Montreal, Canada; 4Departments of
Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor; 5Bermuda Eye Institute; 6Molecular Genetics and Pathol-
ogy Unit, Hospital of Divino Espírito Santo, Panto Delgada, São Miguel Island, Azores; 7Instituto Gulbenkian de Ciências, Oeiras,
Portugal; 8 Center for Molecular Life Sciences, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
Purpose: To identify the causative gene mutations in three siblings with severe progressive autosomal recessive cone-rod
dystrophy (arCRD) and their fifth paternal cousin with Stargardt disease (STGD1) and to specify the phenotypes.
Methods: We evaluated eight sibs of one family, three family members displayed arCRD, and one STGD1. All of them
were screened for mutations using a new microarray for autosomal recessive retinitis pigmentosa.
Results: We found a new pathologic ATP-binding cassette transporter (ABCA4) splice-site mutation, c.3523-2A>T and
the previously reported c.5327C>T (p.P1776L) missense mutation in the arCRD patients. The three siblings shared these
two ABCA4 mutations and showed similar phenotypes. An unusual aspect was nystagmus which presented in one of the
arCRD patients. In the STGD1 patient we found the c.5327C>T (p.P1776L) missense mutation and a novel c.868C>T
(p.R290W) missense mutation.
Conclusions: Two new ABCA4 mutations were identified in a family with arCRD and STGD1. A new finding was nystag-
mus associated with arCRD in one of the patients.
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Methods:  DNA was isolated using the Qiagen DNA iso-
lation kit. DNA samples were then analyzed with the arRP-I
array. This newly developed custom designed array contained
oligonucleotides created from the exons and 5 bp of flanking
intronic sequences from 11 of the 19 currently known arRP
genes: ABCA4, CNGA1, CRB1, MERTK, PDE6A, PDE6B,
RGR, RHO, RLBP1, RPE65, and TULP1 [26]. DNA from pa-
tient VI-1 was sequenced bidirectionally for all coding exons
using gene-specific PCR primers as described in Table 1 [26].
The PCR products were purified using the Millipore purifica-
tion system and thereafter analyzed on ABI3730 or ABI3100
DNA analyzers. Automatic analysis was done by ABI
basecaller.
The c.868C>T (p.R290W) sequence change was tested
in DNA from 92 anonymous healthy Dutch blood donors and
95 healthy blood donors from the São Miguel island (Azores,
Portugal). This was done, by amplifying exon 8 of the ABCA4
gene and, followed by restriction fragment length polymor-
phism (RFLP) analysis using EagI. The amplicon consisted
of 400 bp, which in the case of a wild-type allele was cut by
EagI into fragments of 80 and 320 bp fragments. EagI does
not cut the mutated allele.
Patients:  The pedigree consisted of three siblings affected
with arCRD and a fifth paternal cousin affected with STGD1
(Figure 1). Genealogic studies revealed that IV:1, IV:2, V:7,
and V:8 originated from São Miguel, which is part of the Azore
Archipelago. All clinical data were analyzed retrospectively,
and additional information was collected through ophthalmic
examination including best corrected visual acuity, slit-lamp
examination, funduscopy, electroretinography (ERG), and
Goldmann perimetry.
RESULTS
 Several likely benign sequence variants in the ABCA4 gene
were identified in patient V:6 with the arRP-I chip: c.141A>G
(p.P47P), c.1268A>G (p.H423R), c.5603A>T (p.N1868I),
c.5682C>G (p.L1894L), c.6069T>C (p.I2023I) and
c.4203C>A (p.P1401L). In addition, two likely pathologic
variants were identified in ABCA4, c.3523-2A>T and
c.5327C>T (p.P1776L). Additional sequence analysis was
performed to confirm the presence of these two mutations,
and several intronic sequence changes were then identified
(c.302+26A>G, c.859-32T>C, c.1239+18C>A,
c.1239+28C>A, c.1356+11delG, c.4352+54A>G, c.5585-
51Adel and c.6817-49C>G). Indeed, sequence analysis con-
firmed the presence of the two likely pathologic variants.
Sequence analysis of V:2 and V:5 revealed the same mu-
tations. The three unaffected siblings and the mother of the
patients only carried the c.3523-2A>T mutation.
Further investigation of the family history revealed a fifth
paternal cousin with STGD1.
Direct sequence analysis of the DNA of patient VI:1 iden-
tified the c.5327C>T (p.P1776L) missense mutation and re-
vealed a novel ABCA4 sequence change, c.868C>T
©2007 Molecular VisionMolecular Vision 2007; 13:1568-72 <http://www.molvis.org/molvis/v13/a174/>
TABLE 1. FORWARD AND REVERSE PRIMERS FOR POLYMERASE CHAIN
REACTION AMPLIFICATION OF ABCA4 EXONS
                                                                Ann
                                                                temp
Exon   Forward primer 5'- 3'     Reverse primer 5' - 3'   bp    (°C)
----   -----------------------   ----------------------   ---   ----
1      GACCAATCTGGTCTTCGTG       GTTTATTTGCTCCACACCTC     145   56
2      TAGCACCACTGAACTTTCTCT     AAGGCCCAGACCAAAGTCTC     191   58
3      CCTGCTTGGTCTCCATGAC       ACGTGAAGGGGTGTGCAAC      249   58
4      GCTATTTCCTTATTAATGAGGC    CCAACTCTCCCTGTTCTTTC     259   58
5      GACCCATTTCCCCTTCAAC       AGGCTGGGTGCTTCCCTC       230   56
6      CTTTCCTACCACAGGGCAG       AGGAATCACCTTGCAATTGG     289   58
7      TGCCTATGTGTGTATATACC      TAAGTGGGGTAAATGGTGG      220   58
8      GAGCATTGGCCTCACAGCAG      TTAACCAACATGAGAGGCC      356   56
9      AAGCAATGGGGAGTTTCTGT      GAGATGTGATACCAGGAAG      289   58
10     GACACACCAAAAGTTCTCTCT     TCCCCTCCCCTCCCCATC       222   58
11     CTAAGCAGAGCAGTGACTG       ACTTGACTTGCTAAGGGAG      314   58
12     GGTCCTCCTCACACTCTCT       ATTTCCCACTGACTTTGGAG     286   58
13     GAGGTGTGAGTGAGCTATCC      CCCATTAGCGTGTCATGG       282   58
14     CCTCTACCAGGTACAGAGC       GGGAAAGGAACCAAAGTATTC    330   58
15     AGGCTGGTGGGAGAGAGC        AGTGGACCCCCTCAGAGG       407   58
16     CTGTTGCATTGGATAAAAGGC     GATGAATGGAGAGGGCTGG      330   58
17     CTGCGGTAAGGTAGGATAGGG     CACACCGTTTACATAGAGGGC    232   58
18     CCTCTCCCCTCCTTTCCTG       GTCAGTTTCCGTAGGCTTC      279   58
19     TGGGGCCATGTAATTAGGC       TGGGAAAGAGTAGACAGCCG     322   58
20     ACTGAACCTGGTGTGGGG        TATCTCTGCCTGTGCCCAG      325   60
21     GTAAGATCAGCTGCTGGAAG      GAAGCTCTCCTGCTCCAAGC     301   58
22     CACCCTCCACAGCCCCTTAAC     TCGTTGTGGTTCCTGTACTCAG   291   58
23     TTTTTGCAACTATATAGCCAGG    AGCCTGTGTGAGTAGCCATG     384   58
24     GCATCAGGGAGAGGCTGTC       CCCAGCAATATTGGGAGATG     212   54
25     GGTAACCTCACAGTCTTCC       GGGAACGATGGCTTTTTGC      379   58
26     CAAAACAGAGCTGGGTTAG       ACTTTCGAGATGGAACTTGG     191   58
27     GCTACCAGCCTGGTATTTCATTG   GTTATAACCCATGCCTGAAG     493   56
28     CCACCAGGGGCTGATTAG        CCCAAACCCACACAGAGGAG     289   58
29     GTTGCATGATGTTGGCACG       TCTTAGGACAGGGGCGCG       185   58
30     GTCAGCAACTTTGAGGCTG       ACTCAGGAGATACCAGGGAC     314   58
31     TAAGTCCTCAAGTTCCAAGG      TCTTCTACAGGGCAGCCAG      193   58
32     GAAAGTTAACGGCACTGCT       CATGGATGTGAGGTGTGC       185   58
33     TTCATGTTTCCCTACAAAACCC    CATGAGAGTTTCTCATTCATGG   265   58
34     GCTTAACTACCATGAATGAG      ATTCCTTGCTAGATTTCAGC     286   56
35     GCAGCGTCTCCAATGTCCTC      AAGAGTGGAGAAGGTGACAAG    255   58
36     GTATCTTCTCCTCCTTGTGC      ACACACAAGCTCCACCTTG      304   58
37     TTGCAGAGCTGGCAGCAG        CCACCAGGCTTCTCTTCAG      226   58
38     GGAATGGAATGTGGAACTCC      CACATACTCTACTATCCTAC     253   58
39     TGCTGTCCTGTGAGAGCATC      TCCCAGCTTTGGACCCAG       268   58
40     CCAGGTCTGTGGGGTGAG        AGTTCTGGATGCCCTGAG       241   60
41     GGACACTGTACAGCCAGC        GACGAGTTATAACACAGGG      319   58
42     CTCCTAAACCATCCTTTGCTC     AGGCAGGCACAAGAGCTG       214   58
43     CTTACCCTGGGGCCTGAC        CTCAGAGCCACCCTACTATAG    277   58
44     GAAGCTTCTCCAGCCCTAGC      TGCACTCTCATGAAACAGGC     287   58
45     GTTTGGGGTGTTTGCTTGTC      ACCTATTTCCCCAACCCAAGAG   257   58
46     GAAGCAGTAATCAGAAGGGC      GCCTCACATTCTTCCATGCTG    256   58
47     TCACATCCCACAGGCAAGAG      AGGTGGATCCACAGAAGGC      256   58
48     GATTACCTTAGGCCCAACC       ACACTGGGTGTTCTGGACC      228   60
49     GTGTAGGGTGGTGTTTTCC       AAGCCCAGTGAACCAGCTGG     365   58
In this table bp represents base pair, Ann temp represents annealing
temperature.
Figure 1. Pedigree and ABCA4 sequence variants.  In this illustra-
tion, a slash indicates a deceased individual. Squares, represent males,
while circles represent females. Black shading denotes family mem-
bers affected with arCRD. The gray circle marks affected an indi-
vidual with STGD1.
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(p.R290W). The c.868C>T (p.R290W) sequence change was
not detected in the DNA from 92 healthy Dutch controls or
from of 95 healthy individuals from São Miguel island.
Clinical evaluation:  Unfortunately, no early clinical data
were available for our CRD patients. The siblings affected
with CRD were in their early 40s at the time they first visited
our ocular genetics clinic. On history, however, all siblings
reported visual acuity difficulties since early childhood fol-
lowed by peripheral field loss in the second decade. Night
blindness occurred in the third decade.
Initial visual acuity test results ranged from light percep-
tion to counting fingers. Patient V:2 showed distinct pendular
nystagmus. Anterior segments were normal in all three pa-
tients. Funduscopy revealed pale optic disks with severely at-
tenuated retinal vessels in all three patients. Individuals V:2
and V:5 showed distinct atrophy of the RPE in the macular
area (Figure 2 and Figure 3). Bone spicule pigmentations were
evident throughout the retina in V:2, and limited to the poste-
rior pole and midperiphery in patient V:5. Patient V:6 showed
heavy bone spicule pigmentation throughout the entire retina
with extensive macular involvement. On ERG, no detectable
signals were found in all three patients. Goldmann kinetic
perimetry revealed small temporal islands with target V4-e in
the arCRD patients.
Patient VI:1 was 11 years old when she received the di-
agnosis of STGD1 at another institution. At 52 years, visual
acuity of the right eye was counting fingers whereas visual
acuity of her left eye was hand movements. Funduscopy re-
vealed normal optic disks, mild attenuation of the vessels, and
large atrophic lesions in both maculae. Lobular atrophy of the
RPE was seen in the mid and peripheral regions (Figure 4).
DISCUSSION
 A family with arCRD and STGD1 was investigated using a
new arRP-I array designed to detect mutations in 11 arRP genes
including ABCA4. In hindsight, the use of the arRP-I chips in
this particular pedigree was not logical given the indication of
ABCA4 involvement through the ascertainment of the fifth
paternal cousin with STGD1. Instead, a much cheaper tech-
nique, arrayed primer extension (APEX)-based analysis of the
known ABCA4 variants (ABCR500) could have been used.
The ABCR500 array would also have identified one of the
alleles in both branches of the pedigree.
In three siblings with arCRD, both mutations in the ABCA4
gene were found, i.e., the c.5327C>T (p.P1776L) mutation
previously described in a STGD1 patient [10] and a new splice
site mutation; c.3523-2A>T. Direct sequencing of DNA of a
fifth paternal cousin with STGD1 from Bermuda (but from
São Miguel island origin) revealed the c.5327C>T (p.P1776L)
mutation and a new variant, c.868C>T (p.R290W).
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Figure 2. Fundus photograph of the left eye of patient V:2, age 46
years.  Evident in this photograph are the attenuated vessels, the atro-
phic lesion in the macula, and bone-spicule pigmentations.
Figure 3. Fundus photograph of the right eye of patient V:5, age 43
years.  Note the pale optic disk, moderate attenuation of the vessels,
and heavy bone-spicule pigmentation in the midperiphery with a rela-
tively spared periphery.
Figure 4. Fundus photograph of the left eye of patient VI:1, age 52.
This photograph clearly shows the relatively normal optic disk, mild
attenuation of the vessels, and large atrophic lesion with scattered
pigmentations in the macula. The retinal pigment epithelium has a
lobular atrophic appearance.
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The arginine at position 290 resides in the first intradiskal
loop of ABCR and is conserved in human, mouse, rat, dog,
and Xenopus. The change from a basic to neutral/hydropho-
bic residue is likely to have functional implications. The pro-
line residue at position 1776 resides in the middle of a stretch
of hydrophobic residues constituting the ninth transmembrane
domain of ABCR.
Biochemical analysis of recombinant ABCR bearing these
mutations was not performed. The previously presented geno-
type-phenotype model suggest that the residual ABCR pro-
tein activity is inversely correlated to disease severity. There-
fore, the previously identified p.P1776L [10] mutation is likely
a mild or moderately severe mutation, since both the arCRD
and STGD1 sibs shared this mutation. Difference in pheno-
type would have to be explained by the difference in severity
of the c.3523-2A>T (splice site mutation) and the p.R290W
(missense) mutations. Most likely, this splice acceptor site
mutation preceding exon 24 of ABCA4 results in the skipping
of exon 24, which leads to a frameshift and a translational
stopmutation in the third triplet following the exon 23/exon
25 splice junction.
It was difficult to determine the exact clinical diagnosis
(especially the issue of RP versus CRD) in our three patients
as no early ERGs were available. The occurrence of nystag-
mus, which is a new finding in a CRD patient with ABCA4
mutations, supports the history of early loss of central vision.
The loss of visual acuity, followed by night blindness and pe-
ripheral field loss, suggest the diagnosis of CRD. In our three
siblings, the retinal degeneration led to complete loss of the
central retina and almost complete loss of the peripheral retina
with an RP-like appearance by the time they were 40 years
old. This is consistent with the results from Lorenz and
Preising, who suggested that RP caused by ABCA4 mutations
is a severe progressive cone-rod disease [15].
It was not surprising to find some peripheral involvement
in our STGD1 patient since ABCA4 is expressed in both cones
and rods. If there were an ERG available on this patient, one
might assume it would show a cone-rod pattern as seen in a
significant fraction of STGD patients [27].
Several studies are ongoing to design new treatment strat-
egies for retinal dystrophies, some of which are specific for
retinal diseases caused by ABCA4 mutations. Studies with
administration of isotretoin and N-(4-
hydroxyphenyl)retinamide (HPR) to Abcr -/- mice showed
reduction of accumulation of the toxic lipofuscin fluorophores
[28,29].
Given these developments, it is important to identify pa-
tients with ABCA4 mutations, as they may be eligible for fu-
ture therapeutic interventions. Detailed clinical description of
these types of retinal dystrophy patients is essential in order
to facilitate the search for the causal gene.
In conclusion, mutations in the ABCA4 gene should be
considered in patients with arCRD and in older patients pre-
senting with a severe RP-like phenotype and a history of early
central visual acuity loss.
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